<DOC>
	<DOCNO>NCT01687114</DOCNO>
	<brief_summary>This protocol clinical trial validate proanthocyanidin A2 ( PAC-A2 ) useful marker cranberry intake . We hypothesize consumption cranberry beverage progressive dosing schedule increase PAC-A2 excretion urine . Five generally healthy , nonsmoking , pre-menopausal woman ( absent major chronic disease include cardiovascular , endocrine , gastrointestinal , renal condition ) , age 20-40 year , body mass index ( BMI ) 18.5-25 kg/m2 recruit Boston area sexually active woman age range particularly vulnerable urinary tract infection . Volunteers ask consume assign cranberry beverage dose 8 oz/day accord weekly dosing schedule . Relevant clinical information eleven 24-hour morning spot urine sample collect subject study . Urinary PAC-A2 concentration determine validate serve marker compliance cranberry juice consumption .</brief_summary>
	<brief_title>Urinary Proanthocyanidin-A2 Biomarker Compliance Intake Cranberry Products</brief_title>
	<detailed_description>People frequently eat whole grain , fruit berry , vegetable , bean legume , nut , seed , cocoa , tea , wine , fruit vegetable juice may decrease risk disease . It believe health benefit due phytochemical present food beverage . Phytochemicals nutrient naturally present plant-based food beverage . Recently , cranberry contain food beverage believe prevent urinary tract infection . However , cranberry decrease urinary tract infection clear . To good understand phytochemical cranberry may benefit health , want learn absorb eliminate body . Thus , purpose main study see whether measure phytochemical cranberries health volunteer drink cranberry juice .</detailed_description>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Proanthocyanidin</mesh_term>
	<mesh_term>Procyanidin</mesh_term>
	<criteria>generally healthy premenopausal woman age 2040 body mass index ( BMI ) : 18.525 kg/m2 sexually active pregnant planning become pregnant advance plan discontinue use hormonal contraceptive take Use medication know affect lipid metabolism History bilateral mastectomy Use medication know suspected influence blood pressure cardiovascular disease Gastrointestinal disease , Renal chronic kidney disease Endocrine disorder Rheumatologic disease Immune deficiency condition Active treatment cancer type longer 1 Systolic blood pressure &gt; 139 mmHg and/or diastolic blood pressure &gt; 89 mmHg Regular use ( 1x/wk ) acidlowering medication , laxative ( include fiber supplement ) antidiarrheal medication Use antibiotic last month Regular use systemic steroid , oral injectable Gain loss 5 % body weight last 6 mo Any history know allergy cranberry cranberry product Regular use dietary supplement contain vitamin , mineral , herbal plantbased preparation , fish oil supplement homeopathic remedy . Usual daily ethanol intake equal 2 drink Cigarette smoke and/or nicotine replacement use . Strict vegetarian ( vegan ) Pregnancy Infrequent ( &lt; 3/wk ) excessive ( &gt; 3/d ) number regular bowel movement Inability discontinue refrain ASA/NSAID Tylenol use 72 h prior duration test Visits 213 Participation clinical research trial within 60 enrollment visit ( Visit 2 ) Specific laboratory blood urine analysis parameter : Creatinine &gt; 1.5 mg/dL , Electrolytes , calcium , phosphorous normal range , ALT AST &gt; 1.5 nmol , Total bilirubin normal range , Fasting glucose ≥126 mg/dL , Total cholesterol &gt; 239 mg/dL , Triglycerides ≥300 mg/dL , CBC : HCT &lt; 32 % female , normal range male , WBC , PLT normal range , hematuria , proteinuria</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>compliance , proanthocyanidin , phenoic acid , cranberry</keyword>
</DOC>